Dexcom reports preliminary Q4 revenue $1.113B (+8% YoY); guides 2025 revenue $4.60B (+14%)

DEXCOM INC

2024-FY EPS reported $1.42 revenue$4,033,000,000

Q4 2024 preliminary revenue at least $1.113B, up 8% YoY; US revenue $803M (+4%), international $310M (+17%).
FY2024 total preliminary revenue ~$4.032B, up 11% YoY.
Updated 2024 non-GAAP gross margin guidance to 62% and operating margin to 19%; Q4 margin hit by non-cash charge.
2025 revenue guidance $4.60B (+14%); non-GAAP gross margin 64-65%, operating margin ~21%.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.